JP2021505634A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505634A5 JP2021505634A5 JP2020531722A JP2020531722A JP2021505634A5 JP 2021505634 A5 JP2021505634 A5 JP 2021505634A5 JP 2020531722 A JP2020531722 A JP 2020531722A JP 2020531722 A JP2020531722 A JP 2020531722A JP 2021505634 A5 JP2021505634 A5 JP 2021505634A5
- Authority
- JP
- Japan
- Prior art keywords
- cdkn2a
- composition according
- measuring
- expression level
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023163165A JP2023165858A (ja) | 2017-12-12 | 2023-09-26 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
| JP2026025751A JP2026069683A (ja) | 2017-12-12 | 2026-02-19 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762597473P | 2017-12-12 | 2017-12-12 | |
| US62/597,473 | 2017-12-12 | ||
| PCT/US2018/064829 WO2019118389A1 (en) | 2017-12-12 | 2018-12-11 | Cdkn2a companion diagnostic for bladder cancer interferon therapy |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023163165A Division JP2023165858A (ja) | 2017-12-12 | 2023-09-26 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
| JP2026025751A Division JP2026069683A (ja) | 2017-12-12 | 2026-02-19 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021505634A JP2021505634A (ja) | 2021-02-18 |
| JP2021505634A5 true JP2021505634A5 (https=) | 2022-01-11 |
Family
ID=66820952
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020531722A Pending JP2021505634A (ja) | 2017-12-12 | 2018-12-11 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
| JP2023163165A Pending JP2023165858A (ja) | 2017-12-12 | 2023-09-26 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
| JP2026025751A Pending JP2026069683A (ja) | 2017-12-12 | 2026-02-19 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023163165A Pending JP2023165858A (ja) | 2017-12-12 | 2023-09-26 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
| JP2026025751A Pending JP2026069683A (ja) | 2017-12-12 | 2026-02-19 | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20200360499A1 (https=) |
| EP (1) | EP3723780A4 (https=) |
| JP (3) | JP2021505634A (https=) |
| WO (1) | WO2019118389A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019118389A1 (en) | 2017-12-12 | 2019-06-20 | Trizell Limited | Cdkn2a companion diagnostic for bladder cancer interferon therapy |
| KR20230012471A (ko) * | 2020-03-30 | 2023-01-26 | 트리젤 엘티디. | 암 치료용 조성물 및 방법 |
| WO2024014580A1 (ko) * | 2022-07-13 | 2024-01-18 | 이왕재바이오연구소 주식회사 | 엑소좀에서 발현되는 바이오 마커를 이용하는 인공지능 기반 암 진단용 정보제공 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130059303A1 (en) * | 2011-09-06 | 2013-03-07 | Francois Radvanyi | Cdkn2a as a prognostic marker in bladder cancer |
| WO2013131093A1 (en) * | 2012-03-02 | 2013-09-06 | Board Of Regents, The University Of Texas System | The use of a panel of urinary cytokines to predict response to bcg therapy for bladder cancer |
| US20150252412A1 (en) * | 2012-08-31 | 2015-09-10 | Massachusetts Institute Of Technology | High-definition dna in situ hybridization (hd-fish) compositions and methods |
| WO2019118389A1 (en) | 2017-12-12 | 2019-06-20 | Trizell Limited | Cdkn2a companion diagnostic for bladder cancer interferon therapy |
-
2018
- 2018-12-11 WO PCT/US2018/064829 patent/WO2019118389A1/en not_active Ceased
- 2018-12-11 US US16/458,275 patent/US20200360499A1/en not_active Abandoned
- 2018-12-11 JP JP2020531722A patent/JP2021505634A/ja active Pending
- 2018-12-11 EP EP18887796.3A patent/EP3723780A4/en active Pending
-
2022
- 2022-10-13 US US17/965,739 patent/US12178865B2/en active Active
-
2023
- 2023-09-26 JP JP2023163165A patent/JP2023165858A/ja active Pending
-
2026
- 2026-02-19 JP JP2026025751A patent/JP2026069683A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hou et al. | TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis | |
| Chuppa et al. | MicroRNA-21 regulates peroxisome proliferator–activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4 | |
| Wang et al. | MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair | |
| Synnestvedt et al. | Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia | |
| US20250099422A1 (en) | Compositions and methods for treating allergic inflammatory conditions | |
| Mao et al. | Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats | |
| JP2012503013A5 (https=) | ||
| WO2017161387A1 (en) | Compositions of natural extracts and use thereof in methods for preventing or treating diseases | |
| JP2021505634A5 (https=) | ||
| WO2012096411A1 (ja) | 難治性炎症性腸疾患の予防又は治療方法 | |
| Kim et al. | Effect of the presence of brain-derived neurotrophic factor Val66Met polymorphism on the recovery in patients with acute subcortical stroke | |
| CN114432332B (zh) | circUTRN在制备治疗心力衰竭药物中的应用、重组载体和治疗心力衰竭的药物 | |
| JP2017529321A5 (https=) | ||
| CN108096269A (zh) | LncRNA的应用及应用其的药物 | |
| JP2023165858A (ja) | 膀胱がんインターフェロン療法のためのＣＤＫＮ２ａコンパニオン診断 | |
| EP4367240A1 (en) | Compound and method for an allele-specific editing of the elane gene | |
| CN112843078A (zh) | 人参皂苷Rh2在制备防治炎症性肠病药物中的应用 | |
| Dahn et al. | Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes | |
| Chen et al. | Dual delivery of agmatine and microRNA-126b using agmatine-mediated DNA nanotube assemblies for acute lung injury therapy | |
| Zhang et al. | Multidrug resistance gene and its relationship to ulcerative colitis and immune status of ulcerative colitis | |
| CN118873667A (zh) | Lat1抑制剂在制备治疗动脉粥样硬化的药物中的应用 | |
| CN116966302A (zh) | Areg的新用途 | |
| Lee et al. | Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats | |
| CN102643900A (zh) | 鹅过氧化物酶体增殖物激活受体PPARγ基因的单核苷酸多态性检测方法及其应用 | |
| Caroli et al. | Aspergillus fumigatus pneumonia during cyclosporine treatment for ulcerative colitis |